Efficacy and Safety of Nasal Administration of Nano-L-DOPA based on PLGA nanoparticles
Inclusion of L-DOPA,the standard Parkinsons disease medication,into polymeric particles (PLGA) results in optimization the drug metabolism and increasing its bioavailability,significantly increases of physical endurance,better coordination and lower anxiety in Wistar rats,when chronically administered nasally.
nanopaticls L-DOPA nasal administration Parkinsons disease
I.G.Kondrasheva T.A.Antipova G.G.Barsegyan P.Ye.Gambaryan A.A.Guseva A.A.Kamensky
Research Center of Molecular Diagnostics & Therapy Moscow, Russia Moscow State University Moscow, Russia
国际会议
北京
英文
25-27
2012-10-26(万方平台首次上网日期,不代表论文的发表时间)